Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 284 articles:
HTML format



Single Articles


    June 2022
  1. GU D, Cao T, Yi S, Liu Y, et al
    CCCTC-Binding Factor Mediates the Transcription of Insulin-Like Growth Factor Binding Protein 5 Through EZH2 in Ulcerative Colitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07566.
    PubMed     Abstract available


  2. BARNES A, Ooi SJ, Lynch KD, Parthasarathy N, et al
    Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07556.
    PubMed     Abstract available


  3. KUMAR A, Swaminath A
    Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?
    Dig Dis Sci. 2022;67:1927-1929.
    PubMed    


  4. NGUYEN NH, Zhang X, Long MD, Sandborn WJ, et al
    Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2039-2048.
    PubMed     Abstract available


  5. GORDON H, Blad W, Trier Moller F, Orchard T, et al
    UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD.
    Dig Dis Sci. 2022;67:2444-2450.
    PubMed     Abstract available


  6. ROCCHI C, Soliman YY, Massidda M, Vadala di Prampero SF, et al
    Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
    Dig Dis Sci. 2022;67:1948-1955.
    PubMed     Abstract available


  7. SINGH S, Heien HC, Sangaralingham L, Shah ND, et al
    Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-alpha Antagonists in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2022;67:2510-2516.
    PubMed     Abstract available


  8. SERVAIS L, Boschetti G, Meunier C, Gay C, et al
    Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
    Dig Dis Sci. 2022;67:2492-2502.
    PubMed     Abstract available


  9. WATANABE Y, Mizushima T, Okumura R, Fujino S, et al
    Fecal Stream Diversion Changes Intestinal Environment, Modulates Mucosal Barrier, and Attenuates Inflammatory Cells in Crohn's Disease.
    Dig Dis Sci. 2022;67:2143-2157.
    PubMed     Abstract available


  10. COSTABLE NJ, Borman ZA, Ji J, Dubinsky MC, et al
    Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab.
    Dig Dis Sci. 2022;67:2480-2484.
    PubMed     Abstract available


  11. XIE M, Xiong Z, Yin S, Xiong J, et al
    Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation.
    Dig Dis Sci. 2022;67:2232-2243.
    PubMed     Abstract available


    May 2022
  12. ZHANG M, Xie Z, Zhou G, Wang Y, et al
    Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some.
    Dig Dis Sci. 2022 May 31. pii: 10.1007/s10620-022-07542.
    PubMed    


  13. KUMAR A, Shenoy V, Buckley MC, Durbin L, et al
    Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07530.
    PubMed     Abstract available


  14. UCHIYAMA K, Takagi T, Mizushima K, Asaeda K, et al
    Investigation on the Inhibitory Effect of Wnt-5a on Colonic Mucosal Inflammation in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 May 19. pii: 10.1007/s10620-022-07537.
    PubMed     Abstract available


  15. GOTTLIEB ZS, Dolinger M, Kayal M, Rao BB, et al
    Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy-Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07532.
    PubMed    


  16. SIMSEK-ONAT P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, et al
    Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07547.
    PubMed     Abstract available


  17. BUERKLE KS, Vernon-Roberts A, Ho C, Schultz M, et al
    A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 May 5. pii: 10.1007/s10620-022-07507.
    PubMed     Abstract available


  18. HILL E, Nguyen NH, Qian AS, Patel S, et al
    Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07505.
    PubMed     Abstract available


  19. CON D, Vasudevan A
    Real-World Guidance from Artificial Intelligence? Predicting Outcomes of Inflammatory Bowel Disease Using Machine Learning.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07511.
    PubMed    


  20. BRENNER EJ, Long MD, Kappelman MD, Zhang X, et al
    Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence.
    Dig Dis Sci. 2022 May 3. pii: 10.1007/s10620-022-07517.
    PubMed     Abstract available


  21. GEORGOPOULOS I, Mavrigiannaki E, Stasinopoulou S, Renieris G, et al
    Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice.
    Dig Dis Sci. 2022;67:1783-1793.
    PubMed     Abstract available


    April 2022
  22. WANG G, Karimi N, Willmann L, Pipicella J, et al
    A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 30. pii: 10.1007/s10620-022-07494.
    PubMed     Abstract available


  23. FAN Y, Delgado-Aros S, Valdecantos WC, Janak JC, et al
    Characteristics of Patients with Crohn's Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07491.
    PubMed     Abstract available


  24. DALAL RS, McClure EL, Marcus J, Allegretti JR, et al
    Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 12. pii: 10.1007/s10620-022-07472.
    PubMed     Abstract available


  25. EMERSON C, Skvarc D, Fuller-Tyszkiewicz M, Olive L, et al
    Self-Worth Beliefs Predict Willingness to Engage in Psychotherapy for Fatigue in Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Apr 8. pii: 10.1007/s10620-022-07476.
    PubMed     Abstract available


  26. CAPLAN A, McConnell R, Velayos F, Mahadevan U, et al
    Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Apr 7. pii: 10.1007/s10620-022-07490.
    PubMed     Abstract available


  27. DE JONG ME, Nagtegaal ID, Vos S, van der Post RS, et al
    Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    Dig Dis Sci. 2022 Apr 5. pii: 10.1007/s10620-022-07485.
    PubMed     Abstract available


  28. MACEDO SILVA V, Freitas M, Boal Carvalho P, Dias de Castro F, et al
    Apex Score: Predicting Flares in Small-Bowel Crohn's Disease After Mucosal Healing.
    Dig Dis Sci. 2022;67:1278-1286.
    PubMed     Abstract available


  29. TSIAOUSSIS GI, Christaki E
    Is the APEX Score the Pinnacle of Predictive Scoring Systems of Disease Flare in Crohn's Patients with Documented Mucosal Healing?
    Dig Dis Sci. 2022;67:1092-1094.
    PubMed    


  30. HORST S
    Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
    Dig Dis Sci. 2022;67:1090-1091.
    PubMed    


  31. DAI C, Huang YH
    Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery.
    Dig Dis Sci. 2022;67:1421-1422.
    PubMed    


  32. LEE HS, Chiorean MV, Boden E, Lord J, et al
    Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn's Disease-Related Strictures.
    Dig Dis Sci. 2022;67:1295-1302.
    PubMed     Abstract available


    March 2022
  33. DEKA D, D'Inca R, Sturniolo GC, Das A, et al
    Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 22. pii: 10.1007/s10620-022-07467.
    PubMed     Abstract available


  34. SASSON G, Kirby CH, Hamilton MJ, Winter RW, et al
    Serving Up a Mediterranean Remission in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 19. pii: 10.1007/s10620-022-07447.
    PubMed    


  35. SLEUTJES JAM, Roeters van Lennep JE, de Vries AC
    Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Mar 18. pii: 10.1007/s10620-022-07449.
    PubMed    


  36. AJBAR A, Cross E, Matoi S, Hay CA, et al
    Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07452.
    PubMed     Abstract available


  37. CORCORAN RM, MacDonagh P, O'Connell F, Morrissey ME, et al
    Association Between Ex Vivo Human Ulcerative Colitis Explant Protein Secretion Profiles and Disease Behaviour.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07411.
    PubMed     Abstract available


  38. AKIYAMA S, Ollech JE, Traboulsi C, Rai V, et al
    Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07405.
    PubMed     Abstract available


  39. AKIYAMA S, Cohen NA, Steinberg JM, Friedberg S, et al
    Rare and Well Done: Endoscopic Control of Colonic Hemorrhage in Severe Ulcerative Colitis.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07446.
    PubMed    


  40. XIAO Y, Benoit N, Sedano R, Jairath V, et al
    Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07439.
    PubMed     Abstract available


  41. GUILLO L, Amiot A, Serrero M, Altwegg R, et al
    Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07445.
    PubMed     Abstract available


  42. YU Y, Zhao H, Luo Y, Lou J, et al
    Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
    Dig Dis Sci. 2022;67:997-1006.
    PubMed     Abstract available


  43. YI Y, Sossenheimer PH, Erondu AI, Skowron KB, et al
    Using Wearable Biosensors to Predict Length of Stay for Patients with IBD After Bowel Surgery.
    Dig Dis Sci. 2022;67:844-853.
    PubMed     Abstract available


    February 2022
  44. WU RY, Tandon P, Ambrosio L, Dunsmore G, et al
    Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study.
    Dig Dis Sci. 2022 Feb 24. pii: 10.1007/s10620-022-07430.
    PubMed     Abstract available


  45. FUJIYA M, Kawaguchi T, Arai S, Isogawa N, et al
    Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07388.
    PubMed     Abstract available


  46. PEMMASANI G, Loftus EV, Tremaine WJ
    Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Feb 10. pii: 10.1007/s10620-022-07385.
    PubMed     Abstract available


  47. FAYE AS
    Connecting the Dots: IBD and Frailty.
    Dig Dis Sci. 2022;67:406-407.
    PubMed    


  48. HUDHUD D, Stashek K, George L, Cross RK, et al
    An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn's Disease.
    Dig Dis Sci. 2022;67:453-456.
    PubMed    


  49. SHARMA N, Savelkoul E, Disney B, Shah A, et al
    A Multicenter Study of Patient Acceptability of the IBD Disk Tool and Patient-Reported Disabilities.
    Dig Dis Sci. 2022;67:457-462.
    PubMed     Abstract available


  50. HANZEL J, Almradi A, Istl AC, Yang ML, et al
    Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
    Dig Dis Sci. 2022;67:646-660.
    PubMed     Abstract available


    January 2022
  51. KIM SH, Park Y, Kim SP, Lee SH, et al
    Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.
    Dig Dis Sci. 2022 Jan 30. pii: 10.1007/s10620-021-07328.
    PubMed     Abstract available


  52. CLARKE K, Pelton M, Stuart A, Tinsley A, et al
    COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2022 Jan 29. pii: 10.1007/s10620-021-07377.
    PubMed     Abstract available


  53. KOBAYASHI M, Yamashita R, Ichikawa R, Shibutani M, et al
    Ectopically Localized Epithelial Cell Clumps in Ulcers Are Derived from Reserved Crypt Stem Cells in a Mouse Model of Ulcerative Colitis.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07340.
    PubMed     Abstract available


  54. VELAYOS FS, Lee JK
    Endoscopic Surveillance and Dysplasia Management in IBD: Plus Ca Change, Plus C'est la Meme Chose.
    Dig Dis Sci. 2022;67:81-84.
    PubMed    


  55. LITTLE RD, Chu IE, Ward MG, Sparrow MP, et al
    De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months.
    Dig Dis Sci. 2022;67:259-262.
    PubMed     Abstract available


  56. SHIGA H, Abe I, Kusaka J, Shimoyama Y, et al
    Capsule Endoscopy Is Useful for Postoperative Tight Control Management in Patients with Crohn's Disease.
    Dig Dis Sci. 2022;67:263-272.
    PubMed     Abstract available


    December 2021
  57. HONG SJ, Katz S
    Frailty, Thy Diagnosis Is Uncertain: Impact on IBD Readmission and Mortality.
    Dig Dis Sci. 2021;66:4070-4071.
    PubMed    


  58. VEYRE F, Boschetti G, Meunier C, Cuerq C, et al
    Low Levels of Fecal Calprotectin 3 Months After Surgery Predict Subsequent Endoscopic Postoperative Remission in Crohn's Disease.
    Dig Dis Sci. 2021;66:4429-4435.
    PubMed     Abstract available


  59. FAYE AS, Wen T, Soroush A, Ananthakrishnan AN, et al
    Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.
    Dig Dis Sci. 2021;66:4178-4190.
    PubMed     Abstract available


    November 2021
  60. DOU D, Ji Y, Zheng J, Li J, et al
    A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4(+)T Cells into Th1 Cells.
    Dig Dis Sci. 2021 Nov 9. pii: 10.1007/s10620-021-07300.
    PubMed     Abstract available


  61. LU J, Liu D, Tan Y, Li R, et al
    Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
    Dig Dis Sci. 2021;66:3803-3812.
    PubMed     Abstract available


  62. HONG SJ, Jang J, Berg D, Kirat T, et al
    Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
    Dig Dis Sci. 2021;66:3753-3759.
    PubMed     Abstract available


    October 2021
  63. XU F, Carlson SA, Liu Y, Greenlund KJ, et al
    Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017.
    Dig Dis Sci. 2021 Oct 11. pii: 10.1007/s10620-021-07264.
    PubMed     Abstract available


  64. RABINOWITZ LG, Zylberberg HM, Yang J, Gold SL, et al
    De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Oct 6. pii: 10.1007/s10620-021-07257.
    PubMed     Abstract available


  65. RAKOWSKY ST, Feuerstein JD
    Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn's Patients.
    Dig Dis Sci. 2021;66:3226-3227.
    PubMed    


  66. LUO Y, Cheng Q, Fang Y, Yu J, et al
    Infliximab Therapy in Very Early Onset Crohn's Disease: Real-World Experience in China.
    Dig Dis Sci. 2021;66:3555-3562.
    PubMed     Abstract available


  67. ZHANG J, Li Y, Diao Y, Da B, et al
    Long-Term Outcome of Endoscopic Balloon Dilation for Duodenal Crohn's Disease-Associated Strictures.
    Dig Dis Sci. 2021;66:3570-3577.
    PubMed     Abstract available


  68. YARUR AJ, Deepak P, Vande Casteele N, Battat R, et al
    Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:3563-3569.
    PubMed     Abstract available


  69. BORREN NZ, Paulides E, Frinack JL, Olson RN, et al
    Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study.
    Dig Dis Sci. 2021;66:3548-3554.
    PubMed     Abstract available


    September 2021
  70. SELINGER CP, Rafferty H, Mooney P, Donnellan C, et al
    Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates.
    Dig Dis Sci. 2021;66:3209-3210.
    PubMed    


  71. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    


  72. DE SA BRITO FROES R, da Luz Moreira A, Carneiro AJV, Moreira JPL, et al
    Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
    Dig Dis Sci. 2021;66:2925-2934.
    PubMed     Abstract available


  73. ZHANG B, Su X, Xie Z, Ding H, et al
    Inositol-Requiring Kinase 1 Regulates Apoptosis via Inducing Endoplasmic Reticulum Stress in Colitis Epithelial Cells.
    Dig Dis Sci. 2021;66:3015-3025.
    PubMed     Abstract available


  74. KIM JY, Park SH, Park JC, Noh S, et al
    The Clinical Significance of Anastomotic Ulcers After Ileocolic Resection to Predict Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2021;66:3132-3140.
    PubMed     Abstract available


  75. ZEZE K, Hirano A, Torisu T, Esaki M, et al
    Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn's Disease: A Retrospective Study.
    Dig Dis Sci. 2021;66:3124-3131.
    PubMed     Abstract available


  76. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available


    August 2021
  77. JAMPALA N, Jain A, Herfarth HH, Long MD, et al
    Personalized Best: Toward Improving Care in Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07221.
    PubMed    


  78. SATO M, Fujii K, Takagi H, Shibuya I, et al
    Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07237.
    PubMed     Abstract available


  79. ISHIDA N, Miyazu T, Tamura S, Tani S, et al
    Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 30. pii: 10.1007/s10620-021-07233.
    PubMed     Abstract available


  80. KAYAL M, Bhagya Rao B, Bhattacharya A, Ungaro R, et al
    Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
    Dig Dis Sci. 2021 Aug 20. pii: 10.1007/s10620-021-07220.
    PubMed    


  81. DAI C, Jiang M, Huang YH
    COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China.
    Dig Dis Sci. 2021 Aug 19. pii: 10.1007/s10620-021-07169.
    PubMed    


  82. GUERRERO VINSARD D, Karagozian R, Wakefield DB, Kane SV, et al
    Maternal Outcomes and Pregnancy-Related Complications Among Hospitalized Women with Inflammatory Bowel Disease: Report from the National Inpatient Sample.
    Dig Dis Sci. 2021 Aug 18. pii: 10.1007/s10620-021-07210.
    PubMed     Abstract available


  83. TSAI L, Nguyen NH, Ma C, Prokop LJ, et al
    Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Dig Dis Sci. 2021 Aug 11. pii: 10.1007/s10620-021-07200.
    PubMed     Abstract available


  84. PARRA RS, da Rocha JJR, Feres O
    Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery.
    Dig Dis Sci. 2021;66:2840-2841.
    PubMed    


  85. HOU JK
    Antibiotics for Crohn's Disease: What Are We Treating?
    Dig Dis Sci. 2021;66:2478-2480.
    PubMed    


  86. PROCTOR DD
    DDS Perspective: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2489-2492.
    PubMed    


  87. PROCTOR DD
    DDS Profile: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2486-2488.
    PubMed    


  88. PAUL S, Williet N, Nancey S, Veyrard P, et al
    No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.
    Dig Dis Sci. 2021;66:2744-2749.
    PubMed     Abstract available


  89. ALIBAZ-ONER F, Ergelen R, Ergenc I, Seven G, et al
    Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behcet's Disease with Intestinal Involvement and Crohn's Disease.
    Dig Dis Sci. 2021;66:2750-2755.
    PubMed     Abstract available


  90. SHPOLIANSKY M, Roggenbuck D, Pinsker M, Salamon N, et al
    Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Dig Dis Sci. 2021;66:2619-2626.
    PubMed     Abstract available


  91. DA COSTA FERREIRA S, Sadissou IA, Parra RS, Feitosa MR, et al
    Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:2610-2618.
    PubMed     Abstract available


  92. CHATEAU T, Damico F, Zallot C, Mathieu N, et al
    Crohn's Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity.
    Dig Dis Sci. 2021;66:2712-2716.
    PubMed     Abstract available


  93. RHODES JM, Subramanian S, Flanagan PK, Horgan GW, et al
    Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
    Dig Dis Sci. 2021;66:2700-2711.
    PubMed     Abstract available


    July 2021
  94. SALWEN-DEREMER JK, Smith MT, Haskell HG, Schreyer C, et al
    Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders.
    Dig Dis Sci. 2021 Jul 30. pii: 10.1007/s10620-021-07176.
    PubMed     Abstract available


  95. NARULA N, Hu A, Nguyen GC, Rangrej J, et al
    Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07151.
    PubMed     Abstract available


  96. STEWART MJ
    Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07174.
    PubMed    


  97. HEATH EM, Kim RB, Wilson A
    A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07177.
    PubMed     Abstract available


  98. GOLOVICS PA, Gonczi L, Reinglas J, Verdon C, et al
    Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Dig Dis Sci. 2021 Jul 20. pii: 10.1007/s10620-021-07178.
    PubMed     Abstract available


  99. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2021 Jul 14. pii: 10.1007/s10620-021-07130.
    PubMed     Abstract available


  100. RAO S, Borum ML
    Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study.
    Dig Dis Sci. 2021;66:2468-2469.
    PubMed    


  101. DALAL RS, Lichtenstein GR
    Superiority Complex: Do Teaching Hospitals Provide Inferior Care for IBD Patients?
    Dig Dis Sci. 2021;66:2137-2139.
    PubMed    


  102. HUDHUD D, Zhu G, Twaddell W, Bafford A, et al
    "Sarc" Attack: Rectal Bleeding in an Elderly Patient with Small Bowel Crohn's Disease.
    Dig Dis Sci. 2021;66:2190-2193.
    PubMed    


  103. CALABRESE C, Dussias N, Impellizzeri G, Lauro A, et al
    CEing More-Assessing Small Bowel Crohn's with Capsule Endoscopy (CE).
    Dig Dis Sci. 2021;66:2173-2176.
    PubMed     Abstract available


    June 2021
  104. PAULIDES E, Pasma A, Erler NS, van Eijk RLA, et al
    Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07118.
    PubMed     Abstract available


  105. PAREKH R, Zhang X, Ungaro RC, Brenner EJ, et al
    Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07104.
    PubMed     Abstract available


  106. BHAT S, Limdi JK, Cross RK, Farraye FA, et al
    Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07114.
    PubMed     Abstract available


  107. GRANDMOUGIN A, D'Amico F, Remen T, Danese S, et al
    Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 22. pii: 10.1007/s10620-021-07016.
    PubMed     Abstract available


  108. FAWSON S, Dibley L, Smith K, Batista J, et al
    Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.
    Dig Dis Sci. 2021 Jun 19. pii: 10.1007/s10620-021-07109.
    PubMed     Abstract available


  109. STONE ML, Feng M, Forster EM
    COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
    Dig Dis Sci. 2021 Jun 11. pii: 10.1007/s10620-021-07095.
    PubMed     Abstract available


  110. MCCURDY JD, Ellen Kuenzig M, Spruin S, Fung OW, et al
    Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064.
    PubMed     Abstract available


  111. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


  112. JEON Y, Leung D, Lis CA, Wang HL, et al
    Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?
    Dig Dis Sci. 2021;66:1802-1806.
    PubMed    


  113. ARMSTRONG J, Sarhan S
    Observations on the Effect of Electronic Needle Container on Adherence to Adalimumab.
    Dig Dis Sci. 2021;66:2135-2136.
    PubMed    


  114. ABOUBAKR A, Riggs AR, Jimenez D, Mella MT, et al
    Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD.
    Dig Dis Sci. 2021;66:1829-1835.
    PubMed     Abstract available


    May 2021
  115. EMERSON C, Fuller-Tyszkiewicz M, Orr R, Lyall K, et al
    Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 29. pii: 10.1007/s10620-021-07065.
    PubMed     Abstract available


  116. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed     Abstract available


  117. CARON B, Neuville E, Peyrin-Biroulet L
    Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07040.
    PubMed     Abstract available


  118. SYED A, Seoud T, Carleton NM, Thakkar S, et al
    Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-06969.
    PubMed     Abstract available


  119. JOGENDRAN R, Tandon P, Kroeker KI, Dieleman LA, et al
    A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06998.
    PubMed     Abstract available


  120. HAO Y, Yzet C, McBride RB, Stock A, et al
    Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis.
    Dig Dis Sci. 2021 May 2. pii: 10.1007/s10620-021-06970.
    PubMed     Abstract available


  121. WEN T, Faye AS, Lee KE, Friedman AM, et al
    Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06999.
    PubMed     Abstract available


  122. KOCHAR BD, Cai W, Ananthakrishnan AN
    Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06990.
    PubMed     Abstract available


  123. HASHASH JG, Mourad FH
    Perianal Fistulizing Crohn's Disease: No Shortcuts to a Deep Understanding of the Disease.
    Dig Dis Sci. 2021;66:1392-1393.
    PubMed    


  124. JIANG ZF, Zhang L
    LncRNA: A Potential Research Direction in Intestinal Barrier Function.
    Dig Dis Sci. 2021;66:1400-1408.
    PubMed     Abstract available


  125. SCHULTHEISS JPD, Altena S, Clevers MR, Baas D, et al
    Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.
    Dig Dis Sci. 2021;66:1477-1487.
    PubMed     Abstract available


  126. ZHU M, Xu X, Feng Q, Cui Z, et al
    Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Dig Dis Sci. 2021;66:1658-1668.
    PubMed     Abstract available


  127. SINGH AK, Kumar R, Gupta P, Kumar-M P, et al
    FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study.
    Dig Dis Sci. 2021;66:1620-1630.
    PubMed     Abstract available


  128. ROLSTON VS, Kimmel J, Popov V, Bosworth BP, et al
    Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2021;66:1631-1638.
    PubMed     Abstract available


    April 2021
  129. DAI C, Huang YH
    Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dig Dis Sci. 2021 Apr 29. pii: 10.1007/s10620-021-06957.
    PubMed    


  130. VIJAYVARGIYA P, Gonzalez Izundegui D, Calderon G, Tawfic S, et al
    Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal Diseases.
    Dig Dis Sci. 2021 Apr 22. pii: 10.1007/s10620-021-06993.
    PubMed     Abstract available


  131. GUDINO V, Salas A
    Promise of Mesenchymal Stem Cell Lysates in IBD Therapy: Are the Parts Greater than the Whole?
    Dig Dis Sci. 2021;66:932-934.
    PubMed    


  132. WONG K, Isaac DM, Wine E
    Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.
    Dig Dis Sci. 2021;66:954-964.
    PubMed     Abstract available


    March 2021
  133. SOO WT, Costello SP, Bryant RV
    Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 25. pii: 10.1007/s10620-021-06946.
    PubMed    


  134. BARBER GE, Hendler S, Choe M, Keyashian K, et al
    Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06947.
    PubMed     Abstract available


  135. HONAP S, Meade S, Ibraheim H, Irving PM, et al
    Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06932.
    PubMed     Abstract available


  136. BAMIAS G, Kokkotis G, Gizis M, Kapizioni C, et al
    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
    Dig Dis Sci. 2021 Mar 9. pii: 10.1007/s10620-021-06907.
    PubMed     Abstract available


  137. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


  138. CAI W, Cagan A, He Z, Ananthakrishnan AN, et al
    A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:760-767.
    PubMed     Abstract available


    February 2021
  139. BASIL M, Schwartz D, Dalal R, Horst S, et al
    Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06888.
    PubMed     Abstract available


  140. MONTENEGRO ML, Corral JE, Lukens FJ, Ji B, et al
    Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 24. pii: 10.1007/s10620-021-06899.
    PubMed     Abstract available


  141. LUO W, Tian L, Tan B, Shen Z, et al
    Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 20. pii: 10.1007/s10620-021-06831.
    PubMed     Abstract available


  142. VERMA A, Varma S, Freedberg DE, Axelrad JE, et al
    A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06877.
    PubMed     Abstract available


  143. LLANOS-CHEA A, Shapiro JM, Winter RW, Jerger L, et al
    Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
    Dig Dis Sci. 2021 Feb 17. pii: 10.1007/s10620-021-06884.
    PubMed     Abstract available


  144. DALAL RS, Ananthakrishnan AN, Hamilton MJ, Winter RW, et al
    Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dig Dis Sci. 2021 Feb 11. pii: 10.1007/s10620-021-06852.
    PubMed    


  145. BARSKY M, Meserve J, Le H, Collins A, et al
    Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06879.
    PubMed    


  146. SHIRAISHI K, Furukawa S, Yagi S, Mori K, et al
    Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06834.
    PubMed     Abstract available


  147. JAGT JZ, Pothof CD, Buiter HJC, van Limbergen JE, et al
    Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06836.
    PubMed     Abstract available


  148. QI Y, Wu HM, Yang Z, Zhou YF, et al
    New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 1. pii: 10.1007/s10620-021-06837.
    PubMed     Abstract available


  149. GAIDOS JKJ, Kane SV
    Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications.
    Dig Dis Sci. 2021;66:336-337.
    PubMed    


  150. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available


  151. NIV E, Ovadia B, Groisman G, Kopelman Y, et al
    CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.
    Dig Dis Sci. 2021;66:636-639.
    PubMed    


    January 2021
  152. SINH P, Tabibian JH, Biyani PS, Mehta K, et al
    Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Dig Dis Sci. 2021 Jan 25. pii: 10.1007/s10620-020-06818.
    PubMed     Abstract available


  153. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-021-06826.
    PubMed    


  154. IBORRA I, Puig M, Marin L, Calafat M, et al
    Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-020-06807.
    PubMed     Abstract available


  155. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  156. TOWNSEND CM, Khanna R, Wilson AS
    A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-alpha Antagonists.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06773.
    PubMed     Abstract available


    December 2020
  157. FIORUCCI S, Carino A, Baldoni M, Santucci L, et al
    Bile Acid Signaling in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020 Dec 8. pii: 10.1007/s10620-020-06715.
    PubMed     Abstract available


  158. BORREN NZ, Tan W, Jess AT, Li PM, et al
    Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.
    Dig Dis Sci. 2020;65:3672-3678.
    PubMed     Abstract available


  159. GAO XH, Yu GY, Khan F, Li JQ, et al
    Greater Peripouch Fat Area on CT Image Is Associated with Chronic Pouchitis and Pouch Failure in Inflammatory Bowel Diseases Patients.
    Dig Dis Sci. 2020;65:3660-3671.
    PubMed     Abstract available


  160. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available


    November 2020
  161. DULAI PS, Jairath V
    A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06707.
    PubMed     Abstract available


  162. ZHANG Y, Li X, Li Y, Li Y, et al
    DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06697.
    PubMed     Abstract available


  163. BALRAM B, Joshi H, Wong K, Kroeker KI, et al
    Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06704.
    PubMed     Abstract available


  164. DIBLEY L, Khoshaba B, Artom M, Van Loo V, et al
    Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support.
    Dig Dis Sci. 2020 Nov 8. pii: 10.1007/s10620-020-06698.
    PubMed     Abstract available


  165. AXELRAD JE, Sauk JS
    Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
    Dig Dis Sci. 2020;65:3064-3065.
    PubMed    


  166. PASTORELLI L, Bezzio C, Saibeni S
    Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy.
    Dig Dis Sci. 2020;65:3066-3068.
    PubMed    


  167. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available


    October 2020
  168. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.
    PubMed    


  169. SCRIBANO ML
    Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06624.
    PubMed     Abstract available


  170. NGUYEN ALH, Sparrow MP
    Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06662.
    PubMed     Abstract available


  171. KARASKOVA E, Pospisilova D, Velganova-Veghova M, Geryk M, et al
    Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06652.
    PubMed     Abstract available


  172. VAN GENNEP S, de Boer NKH, Gielen ME, Rietdijk ST, et al
    Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06647.
    PubMed     Abstract available


  173. SITKIN S, Pokrotnieks J
    Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06650.
    PubMed     Abstract available


  174. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Oct 10. pii: 10.1007/s10620-020-06638.
    PubMed     Abstract available


  175. COSTRINI NV
    Clearing of the Clouds in Inflammatory Bowel Disease Management.
    Dig Dis Sci. 2020 Oct 3. pii: 10.1007/s10620-020-06635.
    PubMed     Abstract available


  176. CAPPELL MS
    Improving the Safety of Endoscopy in Pregnancy: Approaching Gravidity with Gravitas.
    Dig Dis Sci. 2020;65:2745-2748.
    PubMed    


  177. WEINGARDEN AR, Smith P, Streett S, Triadafilopoulos G, et al
    A Failure to Communicate: Disentangling the Causes of Perianal Fistulae in Crohn's Disease and Anal Squamous Cell Cancer.
    Dig Dis Sci. 2020;65:2806-2809.
    PubMed    


    September 2020
  178. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


  179. XIU MX, Liu YM, Chen GY, Hu C, et al
    Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
    Dig Dis Sci. 2020 Sep 25. pii: 10.1007/s10620-020-06611.
    PubMed     Abstract available


  180. NOMURA E, Sujino T, Hosoe N, Yoshimatsu Y, et al
    Characteristics of the Mucosal Surface on Scanning Electron Microscopy in Patients with Remitting Ulcerative Colitis.
    Dig Dis Sci. 2020 Sep 21. pii: 10.1007/s10620-020-06609.
    PubMed     Abstract available


  181. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  182. BLANEY H, Vu P, Mathew A, Snelling R, et al
    Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06590.
    PubMed     Abstract available


  183. BARSKY M, Meserve J, Le H, Collins A, et al
    Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 1. pii: 10.1007/s10620-020-06568.
    PubMed     Abstract available


  184. BLESL A, Rainer F, Pollheimer M, Kump P, et al
    Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Dig Dis Sci. 2020;65:2730-2734.
    PubMed    


  185. HALLE E, Azahaf M, Duveau N, Lambin T, et al
    Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
    Dig Dis Sci. 2020;65:2664-2674.
    PubMed     Abstract available


  186. CERNOCH PS, Fournier N, Zeitz J, Scharl M, et al
    Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Dig Dis Sci. 2020;65:2654-2663.
    PubMed     Abstract available


    August 2020
  187. MULGUND A, Stein D
    Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year.
    Dig Dis Sci. 2020 Aug 24. pii: 10.1007/s10620-020-06548.
    PubMed    


  188. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06560.
    PubMed     Abstract available


  189. MOKTAN V, Jonica E, Li Z, Hata DJ, et al
    C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma.
    Dig Dis Sci. 2020 Aug 16. pii: 10.1007/s10620-020-06496.
    PubMed    


  190. LOPEZ RN, Day AS
    The Loneliness of Long-Term Thiopurine Monotherapy for Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Aug 7. pii: 10.1007/s10620-020-06512.
    PubMed    


  191. LAM AY, Gutin LS, Nguyen Y, Velayos FS, et al
    Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Aug 4. pii: 10.1007/s10620-020-06521.
    PubMed    


  192. SCOTT FI
    Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?
    Dig Dis Sci. 2020;65:2158-2160.
    PubMed    


  193. COATES MD, Seth N, Clarke K, Abdul-Baki H, et al
    Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2020;65:2379-2387.
    PubMed     Abstract available


    July 2020
  194. PERRY C, Fischer K, Elmoursi A, Kern C, et al
    Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 24. pii: 10.1007/s10620-020-06486.
    PubMed     Abstract available


  195. HIRTEN RP, Stanley S, Danieletto M, Borman Z, et al
    Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study.
    Dig Dis Sci. 2020 Jul 23. pii: 10.1007/s10620-020-06493.
    PubMed     Abstract available


  196. XU F, Wheaton AG, Barbour KE, Liu Y, et al
    Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.
    Dig Dis Sci. 2020 Jul 22. pii: 10.1007/s10620-020-06476.
    PubMed     Abstract available


  197. SHARMA S, Weissman S, Mehta TI, Aziz M, et al
    Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
    Dig Dis Sci. 2020 Jul 21. pii: 10.1007/s10620-020-06497.
    PubMed     Abstract available


  198. OLAIYA B, Renelus BD, Filon M, Saha S, et al
    Trends in Morbidity and Mortality Following Colectomy Among Patients with Ulcerative Colitis in the Biologic Era (2002-2013): A Study Using the National Inpatient Sample.
    Dig Dis Sci. 2020 Jul 16. pii: 10.1007/s10620-020-06474.
    PubMed     Abstract available


  199. ALGABA A, Guerra I, Ricart E, Iglesias E, et al
    Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06424.
    PubMed     Abstract available


  200. NADPARA N, Reichenbach ZW, Ehrlich AC, Friedenberg F, et al
    Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06471.
    PubMed     Abstract available


  201. GUPTA S, Aihara H, Trivedi HD, Srivastava A, et al
    Heading in the Right Dissection: Toward an Endoscopic Cancer Cure in a Patient with Long-Standing Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06465.
    PubMed    


  202. REGNER EH, Green AJ, Bain JL, Kattah MG, et al
    Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jul 10. pii: 10.1007/s10620-020-06449.
    PubMed    


  203. KUMAR A, Teslova T, Taub E, Miller JD, et al
    Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06439.
    PubMed     Abstract available


  204. BACH LE, Taleban S
    Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years.
    Dig Dis Sci. 2020;65:1882-1884.
    PubMed    


  205. RIVIERE P, Laharie D
    Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
    Dig Dis Sci. 2020;65:2044-2045.
    PubMed    


  206. CRESPI M, Dulbecco P, De Ceglie A, Conio M, et al
    Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Dig Dis Sci. 2020;65:1904-1916.
    PubMed     Abstract available


  207. REINGLAS J, Gonczi L, Verdon C, Bessissow T, et al
    Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
    Dig Dis Sci. 2020;65:2046-2053.
    PubMed     Abstract available


  208. LI J, Liu L, Zhao Q, Chen M, et al
    Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Dig Dis Sci. 2020;65:1971-1979.
    PubMed     Abstract available


    June 2020
  209. STEIN DJ
    All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 29. pii: 10.1007/s10620-020-06429.
    PubMed    


  210. FARBER ON, Weingarden A, Lee C, Braxton DR, et al
    Not in the Same Vein: Inflammatory Bowel Disease, Malignancy, and Enterocolic Lymphocytic Phlebitis.
    Dig Dis Sci. 2020 Jun 27. pii: 10.1007/s10620-020-06425.
    PubMed    


  211. BALRAM B, Lubov J, Theoret Y, Afif W, et al
    Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06427.
    PubMed     Abstract available


  212. VISCIDO A, Latella G
    Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of "Non-medical Switch".
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06423.
    PubMed    


  213. DIBLEY L, Hart A, Duncan J, Knowles CH, et al
    Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 20. pii: 10.1007/s10620-020-06418.
    PubMed     Abstract available


  214. TANDON P, Lee EY, Maxwell C, Hitz L, et al
    Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06381.
    PubMed     Abstract available


  215. DAI C, Jiang M
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 11. pii: 10.1007/s10620-020-06313.
    PubMed    


  216. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed    


  217. GADHOK R, Gordon H, Sebepos-Rogers G, Baillie S, et al
    UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.
    Dig Dis Sci. 2020;65:1790-1799.
    PubMed     Abstract available


  218. MCCURDY JD, Parlow S, Dawkins Y, Samji K, et al
    Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    Dig Dis Sci. 2020;65:1784-1789.
    PubMed     Abstract available


    May 2020
  219. CUI Y, Zhang J, Chen Y, Chen LG, et al
    Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06350.
    PubMed     Abstract available


  220. ZAIDI D, Wine E
    Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:1288-1290.
    PubMed    


  221. LATELLA G, Viscido A
    Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Dig Dis Sci. 2020;65:1299-1306.
    PubMed     Abstract available


  222. PAINCHART C, Brabant S, Duveau N, Nachury M, et al
    Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
    Dig Dis Sci. 2020;65:1445-1452.
    PubMed     Abstract available


    April 2020
  223. ROTTENSTREICH A, Shifman Z, Grisaru-Granovksy S, Mishael T, et al
    Factors Associated with Inflammatory Bowel Disease Flare During Pregnancy Among Women with Preconception Remission.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06282.
    PubMed     Abstract available


  224. BARBERIO B, Zingone F, Savarino EV
    Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06268.
    PubMed    


  225. COBURN ES, Siegel CA, Winter M, Shah ED, et al
    Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Dig Dis Sci. 2020 Apr 16. pii: 10.1007/s10620-020-06252.
    PubMed     Abstract available


  226. WATANABE C, Nagahori M, Fujii T, Yokoyama K, et al
    Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
    Dig Dis Sci. 2020 Apr 6. pii: 10.1007/s10620-020-06221.
    PubMed     Abstract available


  227. VAN ERP LW, Roosenboom B, Komdeur P, Dijkstra-Heida W, et al
    Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06222.
    PubMed     Abstract available


  228. CASTANO-RODRIGUEZ N, Paramsothy S, Kaakoush NO
    Promise of Fecal Microbiota Transplantation Therapy in Pouchitis.
    Dig Dis Sci. 2020;65:1107-1110.
    PubMed    


  229. OMORI T, Kambayashi H, Murasugi S, Ito A, et al
    Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease.
    Dig Dis Sci. 2020;65:1180-1188.
    PubMed     Abstract available


  230. WU Y, Ghaly S, Kerr S, Jackson B, et al
    Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients.
    Dig Dis Sci. 2020;65:1172-1179.
    PubMed     Abstract available


  231. SONG EM, Lee HS, Kim YJ, Oh EH, et al
    Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2020;65:1189-1196.
    PubMed     Abstract available


    March 2020
  232. LONGHI MS, Kokkotou E
    Lnc-ing RNA Expression with Disease Pathogenesis: MALAT1 and ANRIL in Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 30. pii: 10.1007/s10620-020-06216.
    PubMed    


  233. LEE JS, Lee HS, Jang BI, Kim ES, et al
    Low Bone Mineral Density in Young Patients Newly Diagnosed with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 28. pii: 10.1007/s10620-020-06220.
    PubMed     Abstract available


  234. HAM NS, Hwang SW, Oh EH, Kim J, et al
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06207.
    PubMed     Abstract available


  235. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed     Abstract available


  236. FRIAS GOMES C, Narula N, Morao B, Nicola P, et al
    Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 21. pii: 10.1007/s10620-020-06204.
    PubMed     Abstract available


  237. XU M, Cen M, Shen Y, Zhu Y, et al
    Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Dig Dis Sci. 2020 Mar 20. pii: 10.1007/s10620-020-06208.
    PubMed     Abstract available


  238. CONLEY S, Jeon S, Lehner V, Proctor DD, et al
    Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 19. pii: 10.1007/s10620-020-06213.
    PubMed     Abstract available


  239. SYAL G, Robbins L, Kashani A, Bonthala N, et al
    Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06177.
    PubMed     Abstract available


  240. GU P, Yang E, Chittajallu P, McNeill C, et al
    Patient Perception and Clinical Impact of Direct-to-Consumer Advertising in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06180.
    PubMed     Abstract available


  241. JANSSON-KNODELL CL, Harris CE, Loftus EV Jr, Walker RC, et al
    Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06181.
    PubMed     Abstract available


  242. OKA A, Sartor RB
    Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:757-788.
    PubMed     Abstract available


    February 2020
  243. KO MS, Rudrapatna VA, Avila P, Mahadevan U, et al
    Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06122.
    PubMed     Abstract available


  244. ZHU M, Xie J
    LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.
    Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06093.
    PubMed     Abstract available


  245. HO SSC, Keenan JI, Day AS
    The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.
    Dig Dis Sci. 2020;65:376-390.
    PubMed     Abstract available


    January 2020
  246. LIMSRIVILAI J, Saleh ZM, Johnson LA, Stidham RW, et al
    Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06071.
    PubMed     Abstract available


  247. LAZARO CM, de Oliveira CC, Gambero A, Rocha T, et al
    Evaluation of Budesonide-Hydroxypropyl-beta-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06075.
    PubMed     Abstract available


  248. BERNARD EJ, Fedorak RN, Jairath V
    Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-019-06036.
    PubMed     Abstract available


  249. GIBSON DJ, Doherty GA
    Fast and Curious: An Algorithmic Approach to Infliximab Dosing in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-020-06084.
    PubMed    


  250. BARRETT KE
    DRAwing Conclusions About the Basis of Diarrhea in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 16. pii: 10.1007/s10620-020-06060.
    PubMed    


  251. STATES V, O'Brien S, Rai JP, Roberts HL, et al
    Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Jan 10. pii: 10.1007/s10620-019-05999.
    PubMed     Abstract available


  252. SATYAM VR, Li PH, Reich J, Qazi T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06016.
    PubMed     Abstract available


  253. DUAN M, Cao L, Gao L, Gong J, et al
    Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn's Disease Patients After Stoma Closure.
    Dig Dis Sci. 2020;65:243-249.
    PubMed     Abstract available


  254. YANG Z, Bu C, Yuan W, Shen Z, et al
    Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Dig Dis Sci. 2020;65:150-157.
    PubMed     Abstract available


    December 2019
  255. TORRES P, Canete F, Nunez L, Aguilar A, et al
    Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06010.
    PubMed     Abstract available


  256. GUBATAN J, Triadafilopoulos G, Fernandez-Becker NQ
    Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Dec 11. pii: 10.1007/s10620-019-05994.
    PubMed    


  257. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Dec 2. pii: 10.1007/s10620-019-05953.
    PubMed     Abstract available


    November 2019
  258. SONNENBERG A, Turner KO, Genta RM
    Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 27. pii: 10.1007/s10620-019-05972.
    PubMed     Abstract available


  259. GU P, Patel D, Lakhoo K, Ko J, et al
    Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05967.
    PubMed     Abstract available


  260. BERTANI L, Bodini G, Mumolo MG, de Bortoli N, et al
    Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05959.
    PubMed     Abstract available


  261. GOVANI SM, Berinstein JA, Waljee AK, Stidham RW, et al
    Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Dig Dis Sci. 2019 Nov 20. pii: 10.1007/s10620-019-05957.
    PubMed     Abstract available


  262. BOSSA F, Biscaglia G, Valvano MR, Costantino G, et al
    Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05904.
    PubMed     Abstract available


  263. KIM J, Feagins LA
    Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05934.
    PubMed     Abstract available


  264. BOPARAI ES, Velayos FS, Roy A, Li C, et al
    Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05931.
    PubMed    


  265. PAI YC, Yu LC
    Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?
    Dig Dis Sci. 2019 Nov 7. pii: 10.1007/s10620-019-05933.
    PubMed    


  266. LEVY AN, Ali N, Andrici J, Hamilton MJ, et al
    It's What's Up Front That Counts-Part Two: Esophageal Crohn's Disease Complicated by Recurrent Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05922.
    PubMed    


  267. JUNG YS, Han M, Park S, Cheon JH, et al
    Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2019 Nov 1. pii: 10.1007/s10620-019-05867.
    PubMed     Abstract available


    October 2019
  268. BERRY SK, Takakura W, Bresee C, Melmed GY, et al
    Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05906.
    PubMed     Abstract available


  269. SINGH SP, Chand HS, Banerjee S, Agarwal H, et al
    Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05838.
    PubMed     Abstract available


    September 2019
  270. LIATSOS C, Papaefthymiou A, Tzouvala M, Doulberis M, et al
    Current Aspects on Differentiating Relapses from Over-Infections in Symptomatic Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:2686-2687.
    PubMed    


  271. PAREDES JM, Moreno N, Latorre P, Ripolles T, et al
    Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:2600-2606.
    PubMed     Abstract available


    August 2019
  272. WATANABE Y, Miyoshi N, Fujino S, Takahashi H, et al
    Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Dig Dis Sci. 2019;64:2280-2285.
    PubMed     Abstract available


    July 2019
  273. WASZCZUK L, Waszczuk K, Waszczuk E
    CT in Crohn's Disease Is Beneficial for Patient Care and Should Not Be Feared.
    Dig Dis Sci. 2019;64:2056-2058.
    PubMed    


  274. CLARK-SNUSTAD KD, Singla A, Lee SD
    Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2019;64:1952-1958.
    PubMed     Abstract available


  275. WEISSHOF R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, et al
    Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Dig Dis Sci. 2019;64:1945-1951.
    PubMed     Abstract available


  276. SCHAD CA, Haac BE, Cross RK, Syed A, et al
    Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:1959-1966.
    PubMed     Abstract available


    June 2019
  277. PAPAMICHAEL K, Cheifetz AS
    Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy.
    Dig Dis Sci. 2019;64:1397-1398.
    PubMed    


  278. ANNESE V
    Biosimilars in IBD: Similarity Breeds Contented Patients.
    Dig Dis Sci. 2019;64:1399-1400.
    PubMed    


  279. YARUR AJ, Bruss A, Naik S, Beniwal-Patel P, et al
    Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:1651-1659.
    PubMed     Abstract available


  280. MARTINEZ MJ, Ripolles T, Paredes JM, Moreno-Osset E, et al
    Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2019;64:1640-1650.
    PubMed     Abstract available


  281. VASUDEVAN A, Raghunath A, Anthony S, Scanlon C, et al
    Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Dig Dis Sci. 2019;64:1622-1631.
    PubMed     Abstract available


  282. PLEVRIS N, Jones GR, Jenkinson PW, Lyons M, et al
    Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
    Dig Dis Sci. 2019;64:1660-1667.
    PubMed     Abstract available


    February 2019
  283. MENG Y, Li Y, Hao R, Li X, et al
    Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05491.
    PubMed     Abstract available


    October 2018
  284. MILLER M, Vu KN, Zemek A, Shelton A, et al
    TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5334.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: